logo
Select company
Select metric
$ -6.97MConsolidated Income
VS
Market
38
Sector
72
Industry
51
History
43
$ 0.47Close
$ 0.43 - $ 1.33 52-Week Range
Ticker Information

Ticker

MLSS

Company Name

MILESTONE SCIENTIFIC INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NYSEMKT

MILESTONE SCIENTIFIC INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MLSS - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -6.97M
3/31/2025$ -5.27M
12/31/2024$ -4.71M
9/30/2024$ -4.63M
6/30/2024$ -4.65M
3/31/2024$ -7.1M
12/31/2023$ -6.98M
9/30/2023$ -7.01M
6/30/2023$ -7.52M
3/31/2023$ -8.17M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MILESTONE SCIENTIFIC INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -9.18M.
  • Over the past 5 years, MILESTONE SCIENTIFIC INC's average Cons. Inc. has been $ -6.94M.
  • The median Cons. Inc. for MILESTONE SCIENTIFIC INC during this period was $ -7M
  • MILESTONE SCIENTIFIC INC reached its highest Cons. Inc. over the past 5 years at $ -4.63M.
  • The lowest Cons. Inc. recorded by MILESTONE SCIENTIFIC INC in the same timeframe $ -9.18M

MILESTONE SCIENTIFIC INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
NMTC : NEUROONE MEDICAL TECHNOLOGIES CORP $ -5.34MNXGL : NEXGEL INC $ -2.9MVERU : VERU INC $ -32.71MCUE : CUE BIOPHARMA INC $ -38.9MFEMY : FEMASYS INC $ -21.02MNEPH : NEPHROS INC $ 1.33MPSTV : PLUS THERAPEUTICS INC $ -19.03MOVID : OVID THERAPEUTICS INC $ -38.18MBCAB : BIOATLA INC $ -59.52MALGS : ALIGOS THERAPEUTICS INC $ -74.18M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

MLSS - Consolidated Income, Last 5 years

$ -9.18M

Minimum

Sep 30, 2020

$ -4.63M

Maximum

Sep 30, 2024

$ -6.94M

Average

$ -7M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 11.93M with a standard deviation of $ 116.36M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 376.91M
average$ 11.93M
median$ -2.09M
std$ 116.36M